Insulinotropic action of the monoethyl ester of succinic acid. 1998

L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
Laboratory of Experimental Medicine, Brussels Free University, Belgium.

1. Selected esters of succinic acid are currently under investigation as potential insulinotropic tools in the treatment of non-insulin-dependent diabetes. At variance with the methyl esters of succinic acid used in most of the work so far conducted from this perspective, the monoethyl ester of succinic acid (EMS) offers the advantage of avoiding the undesirable generation of methanol by intracellular hydrolysis. In the present study, the metabolism and functional effects of EMS were investigated, therefore, in rat pancreatic islets. 2. At a 10 mM concentration, EMS enhanced insulin release from islets stimulated by 7-17 mM D-glucose but failed to do so at lower concentrations of the hexose. EMS was efficiently metabolized, as judged from the generation of 14CO2 by islets exposed to the monoethyl ester of either [1,4-14C] or [2, 3-14C]succinic acid. D-Glucose (6 mM) failed to affect the metabolism of EMS (10 mM), which itself failed to affect the metabolism of D-[5-3H]glucose or D-[U-14C]glucose. EMS also stimulated biosynthetic activity in the islets. It inhibited 86Rb and 45Ca outflow from prelabeled islets perfused in the absence of D-glucose but enhanced the efflux of the two cationic tracers in the presence of the hexose (7 mM). 3. It is concluded that the insulinotropic action of EMS is attributable, to a large extent, to its capacity to act as a nutrient in islet cells.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013386 Succinates Derivatives of SUCCINIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,4-carboxy terminated aliphatic structure. Succinic Acids,Acids, Succinic

Related Publications

L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
January 1997, Annals of nutrition & metabolism,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
January 1996, Life sciences,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
January 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
January 1996, Pharmacological research,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
October 1994, The American journal of physiology,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
August 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
December 2006, Journal of biosciences,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
February 2007, Molecular and cellular biochemistry,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
January 2006, Journal of basic and clinical physiology and pharmacology,
L Ladrière, and K Louchami, and C Viñambres, and M M Kadiata, and H Jijakli, and M L Villanueva-Peñacarrillo, and I Valverde, and W J Malaisse
April 1997, European journal of pharmacology,
Copied contents to your clipboard!